DE60324003D1 - Hcv-test - Google Patents

Hcv-test

Info

Publication number
DE60324003D1
DE60324003D1 DE60324003T DE60324003T DE60324003D1 DE 60324003 D1 DE60324003 D1 DE 60324003D1 DE 60324003 T DE60324003 T DE 60324003T DE 60324003 T DE60324003 T DE 60324003T DE 60324003 D1 DE60324003 D1 DE 60324003D1
Authority
DE
Germany
Prior art keywords
antigen
hcv
polyprotein
test
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324003T
Other languages
English (en)
Inventor
Phillip Arcangel
David Chien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Application granted granted Critical
Publication of DE60324003D1 publication Critical patent/DE60324003D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60324003T 2002-09-09 2003-09-08 Hcv-test Expired - Lifetime DE60324003D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40951502P 2002-09-09 2002-09-09
PCT/US2003/028071 WO2004021871A2 (en) 2002-09-09 2003-09-08 Hcv assay

Publications (1)

Publication Number Publication Date
DE60324003D1 true DE60324003D1 (en) 2008-11-20

Family

ID=31978759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324003T Expired - Lifetime DE60324003D1 (en) 2002-09-09 2003-09-08 Hcv-test

Country Status (15)

Country Link
US (1) US7166426B2 (de)
EP (1) EP1546414B1 (de)
JP (2) JP4585314B2 (de)
CN (1) CN1694971B (de)
AT (1) ATE410693T1 (de)
AU (1) AU2003273296B2 (de)
BR (1) BR0314166B8 (de)
CA (1) CA2498228C (de)
DE (1) DE60324003D1 (de)
ES (1) ES2312806T3 (de)
MX (1) MXPA05002641A (de)
NO (1) NO337695B1 (de)
NZ (1) NZ538711A (de)
PL (1) PL209710B1 (de)
WO (1) WO2004021871A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024020A2 (en) 2004-08-27 2006-03-02 Novartis Vaccines And Diagnostics Inc. Hcv non-structural protein mutants and uses thereof
WO2006044923A2 (en) * 2004-10-18 2006-04-27 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis c infection
US20080220448A1 (en) * 2006-09-01 2008-09-11 Blincko Stuart J Antigenic protein conjugates and process for preparing same
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
EP2331125A4 (de) 2008-09-19 2013-03-27 Globeimmune Inc Immuntherapie zur für chronische hepatitis-c-virus-infektionen
BR112012030808A2 (pt) * 2010-06-02 2016-11-01 Mp Biomedicals Asia Pacific Pte Ltd ensaio de vírus da hepatite c de multilinhagem rápido
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN104697988B (zh) * 2015-02-10 2017-10-03 深圳市新产业生物医学工程股份有限公司 检测丙型肝炎病毒抗体的试剂盒及其检测方法和应用
CN111999496A (zh) * 2020-08-20 2020-11-27 必欧瀚生物技术（合肥）有限公司 一种SARS-CoV-2抗原抗体联合检测的试剂盒及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
EP0318216B2 (de) 1987-11-18 2001-08-29 Chiron Corporation NANBV-Diagnostika
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
HUT54896A (en) 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
IT1242183B (it) 1989-12-18 1994-02-16 Wellcome Found Polipeptidi del virus dell'epatite non-a e non-b, post-trasfusionali, procedimento di produzione e corredo per il saggio dei relativi acidi nucleici virali.
JP2733138B2 (ja) 1990-04-04 1998-03-30 カイロン コーポレイション 抗ｈｃｖ抗体の免疫アッセイに使用するｃ型肝炎ウイルス（ｈｃｖ）抗原の組合せ
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
AU719929B2 (en) 1996-05-24 2000-05-18 Grifols Worldwide Operations Limited Multiple epitope fusion protein
AU2001272945A1 (en) 2000-06-15 2001-12-24 Chiron Corporation Immunoassays for anti-hcv antibodies

Also Published As

Publication number Publication date
MXPA05002641A (es) 2005-05-05
ES2312806T3 (es) 2009-03-01
JP4585314B2 (ja) 2010-11-24
BRPI0314166B1 (pt) 2016-06-14
CA2498228A1 (en) 2004-03-18
EP1546414A2 (de) 2005-06-29
BR0314166B8 (pt) 2021-07-27
ATE410693T1 (de) 2008-10-15
CA2498228C (en) 2011-03-22
EP1546414A4 (de) 2006-03-08
AU2003273296A1 (en) 2004-03-29
NO337695B1 (no) 2016-06-06
WO2004021871A2 (en) 2004-03-18
JP2009258128A (ja) 2009-11-05
WO2004021871A3 (en) 2005-02-24
JP2005538355A (ja) 2005-12-15
AU2003273296B2 (en) 2009-11-26
US20040142321A1 (en) 2004-07-22
US7166426B2 (en) 2007-01-23
CN1694971B (zh) 2010-05-26
PL209710B1 (pl) 2011-10-31
NO20051715L (no) 2005-05-23
NZ538711A (en) 2007-01-26
CN1694971A (zh) 2005-11-09
EP1546414B1 (de) 2008-10-08
PL375600A1 (en) 2005-12-12
BR0314166A (pt) 2005-07-19

Similar Documents

Publication Publication Date Title
NO20051715L (no) HCV assay
MXPA02012424A (es) Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.
RS51318B (sr) Varijante imunoglobulina i njihova upotreba
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
WO1999050301A3 (en) Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
EP1412538A4 (de) Verfahren zum gleichzeitigen nachweis von hcv-antigenen und hcv-antikörpern
WO2006033768A3 (en) Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
EP0335135A3 (de) Herstellung von monoklonalen Antikörpern mit Spezifität für mit Hepatitis non A, non B infizierte Leber
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
GR3029320T3 (en) Monoclonal antibodies to putative hcv ns5 proteins and methos for using same.
WO2001093804A3 (en) Hepatitis c virus conjugates
EP1829891A3 (de) Immuntests für Anti-HCV-Antikörper

Legal Events

Date Code Title Description
8364 No opposition during term of opposition